Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
InterMedical Care and Lab Hospital PCLBKK:IMH-R 70 Capex-to-Operating-Income is 0.04 as of Jun. 2026, which is 94% below its 10-year median of 0.66. GuruFocus rates BKK:IMH-R with a GF Score™ of 70/100 and a GF Value™ of ฿5.85 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 346 Healthcare Providers & Services companies, InterMedical Care and Lab Hospital PCL ranks worse than 85.84% on this metric.
Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
InterMedical Care and Lab Hospital PCL (BKK:IMH-R) Capex-to-Operating-Income Explanation
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
InterMedical Care and Lab Hospital PCL Capex-to-Operating-Income Related Terms
InterMedical Care and Lab Hospital PCL Capex-to-Operating-Income Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InterMedical Care and Lab Hospital PCL Capex-to-Operating-Income Chart
InterMedical Care and Lab Hospital PCL Annual Data
BKK:IMH-R vs HCA, THC, EHC: Capex-to-Operating-Income Comparison
For the Medical Care Facilities subindustry, InterMedical Care and Lab Hospital PCL's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InterMedical Care and Lab Hospital PCL Capex-to-Operating-Income vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, InterMedical Care and Lab Hospital PCL's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where InterMedical Care and Lab Hospital PCL's Capex-to-Operating-Income falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Capex-to-Operating-Income of 0.04 mean?
InterMedical Care and Lab Hospital PCL (BKK:IMH-R) has a Capex-to-Operating-Income of 0.04 as of Jun. 2026. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on InterMedical Care and Lab Hospital PCL and its competitors. This is 94% below median its historical median of 0.66. Over the past decade, InterMedical Care and Lab Hospital PCL's Capex-to-Operating-Income has ranged from 0.05 to 1.62. According to the industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #297 out of 346 companies in the Healthcare Providers & Services industry, placing it in the top 85.8%.
Is InterMedical Care and Lab Hospital PCL's Capex-to-Operating-Income too high?
InterMedical Care and Lab Hospital PCL's current Capex-to-Operating-Income of 0.04 is 94% below median its 10-year median of 0.66. Over the past 10 years, this metric has ranged from a low of 0.05 to a high of 1.62. The Healthcare Providers & Services industry median Capex-to-Operating-Income is 0.52. InterMedical Care and Lab Hospital PCL's value of 0.04 is 92.2% below this industry median. Based on the distribution chart, InterMedical Care and Lab Hospital PCL ranks #297 out of 346 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, InterMedical Care and Lab Hospital PCL has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does InterMedical Care and Lab Hospital PCL's Capex-to-Operating-Income compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, InterMedical Care and Lab Hospital PCL ranks #297 out of 346 companies for Capex-to-Operating-Income. This places InterMedical Care and Lab Hospital PCL in the lower half of its industry. The industry median Capex-to-Operating-Income is 0.52. InterMedical Care and Lab Hospital PCL's value of 0.04 is 92.2% below this benchmark. Historically, InterMedical Care and Lab Hospital PCL's own Capex-to-Operating-Income has ranged from 0.05 to 1.62 over the past decade. While the company's 10-year median is 0.66 vs. the industry median of 0.52, InterMedical Care and Lab Hospital PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Capex-to-Operating-Income for a Healthcare Providers & Services company?
The median Capex-to-Operating-Income among Healthcare Providers & Services companies is 0.52, based on 346 companies in the industry. Companies in the top quartile (top 25%) have a Capex-to-Operating-Income significantly above this median, while those in the bottom quartile fall well below. However, Capex-to-Operating-Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InterMedical Care and Lab Hospital PCL's current Capex-to-Operating-Income of 0.04 is 92.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Capex-to-Operating-Income mean?
A high Capex-to-Operating-Income can signal that a stock is expensive relative to its fundamentals. Capex to Operating Income ratio measures a company's investments in physical assets to its operating income. View historical data on InterMedical Care and Lab Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median Capex-to-Operating-Income is 0.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InterMedical Care and Lab Hospital PCL's current Capex-to-Operating-Income is 0.04, which is 94% below median its own 10-year median of 0.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InterMedical Care and Lab Hospital PCL stock overvalued right now?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL (BKK:IMH-R) is currently considered Possible Value Trap. The stock's GF Value™ is ฿5.85, compared to a current price of ฿3.62 — trading 38.1% below its estimated fair value. The current Capex-to-Operating-Income is 0.04, which is 94% below median its 10-year median of 0.66 and 92.2% below the Healthcare Providers & Services industry median of 0.52. InterMedical Care and Lab Hospital PCL's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Capex-to-Operating-Income calculated?
Capex-to-Operating-Income is calculated from a company's financial statements. For InterMedical Care and Lab Hospital PCL (BKK:IMH-R), the current Capex-to-Operating-Income is 0.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InterMedical Care and Lab Hospital PCL (BKK:IMH-R) Overvalued in 2026?
Based on GuruFocus' analysis, InterMedical Care and Lab Hospital PCL stock appears to be undervalued.
The current stock price of ฿3.62 is trading 38.1% below its estimated GF Value™ of ฿5.85.
GuruFocus considers InterMedical Care and Lab Hospital PCL to be Possible Value Trap.
Key valuation signals for BKK:IMH-R:
Capex-to-Operating-Income: 0.04 (94% below median its 10-year median of 0.66)
GF Value™: ฿5.85 vs. price of ฿3.62 (38.1% below fair value)
Industry Position: 92.2% below the Healthcare Providers & Services median (#297 of 346)
No single metric tells the full story. See the BKK:IMH-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InterMedical Care and Lab Hospital PCL is a company principally engaged in specialty medical hospitals, and occupational medicine. The business segments of the firm are Prachapat hospital, Occupational Medicine hospital and Environmental Analysis. Prachapat Hospital is engaged in rendering medical services to patients under government welfare schemes. Occupational Medicine Hospital is engaged in providing physical examination services. Majority of revenue is from Hospital Segment. Geographically, the company operates in Thailand.
70GF Score
Get the complete analysis for BKK:IMH-R
Capex-to-Operating-Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:IMH-R has been successfully added to your 
